Effectiveness of a multidisciplinary risk assessment and management programme—diabetes mellitus (RAMP-DM) on patient-reported outcomes
| Autor: | Karina Hiu Yen Chan, Carlos K. H. Wong, Cindy L. K. Lam, Edmond Pui Hang Choi, Colman Siu Cheung Fung, Anca Ka Chun Chan, Fang Fang Jiao, Eric Yuk Fai Wan |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Longitudinal study medicine.medical_specialty Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Subgroup analysis Risk Assessment law.invention 03 medical and health sciences 0302 clinical medicine Endocrinology Quality of life Randomized controlled trial law Diabetes mellitus Diabetes Mellitus Humans Medicine Longitudinal Studies Patient Reported Outcome Measures Prospective Studies 030212 general & internal medicine Aged Primary Health Care business.industry Disease Management Odds ratio Middle Aged medicine.disease Quality of Life Physical therapy Female Observational study business Risk assessment human activities |
| Zdroj: | Endocrine. 55:416-426 |
| ISSN: | 1559-0100 1355-008X |
| DOI: | 10.1007/s12020-016-1124-1 |
| Popis: | Little is known about how the patient-reported outcomes is influenced by multidisciplinary-risk-assessment-and-management-programme for patients with diabetes mellitus (RAMP-DM). This paper aims to evaluate the effectiveness of RAMP-DM on patient-reported outcomes. This was a prospective longitudinal study on 1039 diabetes mellitus patients (714/325 RAMP-DM/non-RAMP-DM) managed in primary care setting. 536 and 402 RAMP-DM participants, and 237 and 187 non-RAMP-DM participants were followed up at 12 and 24 months with completed survey, respectively. Patient-reported outcomes included health-related quality of life, change in global health condition and patient enablement measured by Short Form-12 Health Survey version-2 (SF-12v2), Global Rating Scale, Patient Enablement Instrument respectively. The effects of RAMP-DM on patient-reported outcomes were evaluated by mixed effect models. Subgroup analysis was performed by stratifying haemoglobin A1c (HbA1c) (optimal HbA1c |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink